CarolJeanCollinsMD

PubMed

• 8 citations
  Mild Idiopathic Infantile Hypercalcemia—Part 1: Biochemical and Genetic Findings
  Nina Lenherr-Taube, Edwin J. Young, Michelle Furman, Yesmino Elia, Esther Assor, David Chitayat, Tami Uster, Susan M. Kirwin, Katherine M. Robbins, Kathleen M B Vinett...> ;The Journal of Clinical Endocrinology and Metabolism. 2021 Sep 27
• 4 citations
  Mild Idiopathic Infantile Hypercalcemia—Part 2: A Longitudinal Observational Study
  Nina Lenherr-Taube, Michelle Furman, Esther Assor, Yesmino Elia, Carol Collins, Kenneth E. Thummel, Michael A. Levine, Etienne Sochett> ;The Journal of Clinical Endocrinology and Metabolism. 2021 Sep 27
• 12 citations
  Identifying common methods used by drug interaction experts for finding evidence about potential drug-drug interactions: Web-based survey
  Amy J. Grizzle, John R. Horn, Carol Collins, Jodi Schneider, Daniel C. Malone, Britney A Stottlemyer, Richard D. Boyce> ;Journal of Medical Internet Research. 2019 Jan 4
• 29 citations
  Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism.
  Haeyoung Zhang, Abdul Basit, Diana Busch, King C. Yabut, Deepak Kumar Bhatt, Marek Drozdzik, Marek Ostrowski, Albert P. Li, Carol Collins, Stefan Oswald, Bhagwat Prasad> ;Biochemical Pharmacology. 2018 Oct 1
• 32 citations
  Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanopa...
  John C. Kraft, Lisa A. McConnachie, Josefin Koehn, Loren Kinman, Jianguo Sun, Ann C. Collier, Carol Collins, Danny D. Shen, Rodney J. Y. Ho> ;Journal of Controlled Release. 2018 Apr 10
• 36 citations
  Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma.
  John C. Kraft, Lisa A. McConnachie, Josefin Koehn, Loren Kinman, Carol Collins, Danny D. Shen, Ann C. Collier, Rodney J. Y. Ho> ;AIDS. 2017 Mar 27
• Exploring the Design and Role of Mobile Apps for Healthcare Providers to Find Teratogenic Information.
  Lie L, Shetty, Gupta K, Polifka Je, Markham G, Albee S, Carol Collins, Gary Hsieh> ;AMIA ... Annual Symposium Proceedings. AMIA Symposium. 2017 Jan 1
• 89 citations
  Transporter expression in liver tissue from subjects with alcoholic or hepatitis C cirrhosis quantified by targeted quantitative proteomics
  Li Wang, Carol Collins, Edward J. Kelly, Xiaoyan Chu, Adrian S. Ray, Laurent Salphati, Guangqing Xiao, Caroline Sunyong Lee, Yurong Lai, Mingxiang Liao, Anita Mathias,...> ;Drug Metabolism and Disposition. 2016 Jan 1
• 5 citations
  Reversible, Time-Dependent Inhibition of CYP3A-Mediated Metabolism of Midazolam and Tacrolimus by Telaprevir in Human Liver Microsomes
  Brian D. Chapron, Linda J. Risler, Brian Phillips, Carol Collins, Kenneth E. Thummel, Danny D. Shen> ;Journal of Pharmacy & Pharmaceutical Sciences. 2015 Mar 25
• 15 citations
  High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients.
  Alenka Jaklič, Carol Collins, Aleš Mrhar, Mohamed L. Sorror, Brenda M. Sandmaier, Meagan J. Bemer, Igor Locatelli, Jeannine S. McCune> ;International Journal of Clinical Pharmacology and Therapeutics. 2013 Sep 1
• 10 citations
  Inhibitory Metabolic Drug Interactions with Newer Psychotropic Drugs: Inclusion in Package Inserts and Influences of Concurrence in Drug Interaction Screening Software
  Richard D. Boyce, Carol Collins, Marc Clayton, John Kloke, John R. Horn> ;The Annals of Pharmacotherapy. 2012 Oct 1
• 73 citations
  Drug-Drug Interaction Potential of Marketed Oncology Drugs: In Vitro Assessment of Time-Dependent Cytochrome P450 Inhibition, Reactive Metabolite Formation and Drug-Dr...
  Jane R. Kenny, Sophie Mukadam, Chenghong Zhang, Suzanne Tay, Carol Collins, Aleksandra Galetin, S. Cyrus Khojasteh> ;Pharmaceutical Research. 2012 Mar 14
• 30 citations
  Designing mobile support for glycemic control in patients with diabetes
  Lynne T. Harris, James T. Tufano, Tung Le, Courtney Rees, Ginny A. Lewis, Alison B. Evert, Jan Flowers, Carol Collins, James Hoath, Irl B. Hirsch, Harold I. Goldberg, ...> ;Journal of Biomedical Informatics. 2010 Oct 1
• 20 citations
  Computing with evidence part II: an evidential approach to predicting metabolic drug-drug interactions
  Richard D. Boyce, Carol Collins, John R. Horn, Ira J. Kalet> ;Journal of Biomedical Informatics. 2009 Dec 1
• 20 citations
  Computing with evidence
  Richard D. Boyce, Carol Collins, John R. Horn, Ira J. Kalet> ;Journal of Biomedical Informatics. 2009 Dec 1
• 8 citations
  Modeling Drug Mechanism Knowledge Using Evidence and Truth Maintenance
  Richard D. Boyce, Carol Collins, John R. Horn, Ira J. Kalet> ;IEEE Transactions on Information Technology in Biomedicine. 2007 Jul 1
• 33 citations
  Risk and Predictability of Drug Interactions in the Elderly
  René H. Levy, Carol Collins> ;International Review of Neurobiology. 2007 Jan 1
• 8 citations
  Prediction of maximum exposure in poor metabolizers following inhibition of nonpolymorphic pathways.
  Carol Collins, René H. Levy, Isabelle Ragueneau-Majlessi, Houda Hachad> ;Current Drug Metabolism. 2006 Mar 31
• 2 citations
  Qualitative pharmacokinetic modeling of drugs.
  Richard D. Boyce, Carol Collins, John R. Horn, Ira J. Kalet> ;AMIA ... Annual Symposium Proceedings. AMIA Symposium. 2005 Jan 1
• Join now to see all